Amir Garakani, MD, DFAPA

• Deepak Cyril Dsouza
• Frank Buono
• John Krystal
• Marc Potenza
• Rajiv Radhakrishnan
• Rani Hoff
• Suchitra Krishnan-Sarin

Anxiety Disorders; Depressive Disorder; Forensic Psychiatry; Personality Disorders; Psychopharmacology; Panic Disorder; Substance-Related Disorders

• Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Frontiers In Psychiatry 2020, 11: 595584. PMID: 33424664, PMCID: PMC7786299, DOI: 10.3389/fpsyt.2020.595584.
• Parsing the effects of comorbid adult ADHD and substance misuse on affective lability in bipolar disorder.Garakani A, Buono FD, Larkin K, Goldberg JF. Parsing the effects of comorbid adult ADHD and substance misuse on affective lability in bipolar disorder. Journal Of Affective Disorders 2020, 266: 338-340. PMID: 32056896, DOI: 10.1016/j.jad.2020.01.087.
• Sublingual Oxytocin With Clozapine in a Patient With Persisting Psychotic Symptoms, Suicidal Thinking With Self-Harm.Garakani A, Buono FD, Marotta RF. Sublingual Oxytocin With Clozapine in a Patient With Persisting Psychotic Symptoms, Suicidal Thinking With Self-Harm. Journal Of Clinical Psychopharmacology 2020, 40: 507-509. PMID: 32701906, DOI: 10.1097/JCP.0000000000001248.
• Forensic PsychiatryAppel, J.M., Garakani, A., Kunz, M. Forensic Psychiatry. In Mount Sinai Expert Guides: Psychiatry,ed. W.K. Goodman, A.B. Simon, A. New, John Wiley & Sons, Ltd., Chichester, West Sussex, UK, 2017, pp. 368-372.
• Sleep-Wake DisordersShenoy, A., Fischer, R., Garakani, A. Sleep-Wake Disorders. In Mount Sinai Expert Guides: Psychiatry,ed. W.K. Goodman, A.B. Simon, A. New, John Wiley & Sons, Ltd., Chichester, West Sussex, UK, 2017, pp. 207-216.
• Neuropsychiatric aspects of concussion.Radhakrishnan R, Garakani A, Gross LS, Goin MK, Pine J, Slaby AE, Sumner CR, Baron DA. Neuropsychiatric aspects of concussion. The Lancet. Psychiatry 2016, 3: 1166-1175. PMID: 27889010, DOI: 10.1016/S2215-0366(16)30266-8.
• Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: A systematic review of the case literature.Garakani A, Jaffe RJ, Savla D, Welch AK, Protin CA, Bryson EO, McDowell DM. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: A systematic review of the case literature. The American Journal On Addictions / American Academy Of Psychiatrists In Alcoholism And Addictions 2016, 25: 358-69. PMID: 27037733, DOI: 10.1111/ajad.12372.
• Schizotypal Personality DisorderGarakani, A., Siever, L.J. Schizotypal Personality Disorder. In The Encyclopedia of Clinical Psychology, 1st Edition, eds. R.L. Cautin, S.O. Lilienfeld, John Wiley & Sons, Inc., Malden, Oxford, UK, 2015, pp. 1–7.
• Heart rate and respiratory response to doxapram in patients with panic disorder.Martinez JM, Garakani A, Aaronson CJ, Gorman JM. Heart rate and respiratory response to doxapram in patients with panic disorder. Psychiatry Research 2015, 227: 32-8. PMID: 25819170, PMCID: PMC4420657, DOI: 10.1016/j.psychres.2015.03.001.
• Voluntary psychiatric hospitalization and patient-driven requests for discharge: a statutory review and analysis of implications for the capacity to consent to voluntary hospitalization.Garakani A, Shalenberg E, Burstin SC, Weintraub Brendel R, Appel JM. Voluntary psychiatric hospitalization and patient-driven requests for discharge: a statutory review and analysis of implications for the capacity to consent to voluntary hospitalization. Harvard Review Of Psychiatry 2014, 22: 241-9. PMID: 24983871, DOI: 10.1097/HRP.0000000000000044.
• Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment.Garakani A, Martinez JM, Yehuda R, Gorman JM. Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment. Journal Of Affective Disorders 2013, 146: 262-5. PMID: 22840611, DOI: 10.1016/j.jad.2012.06.037.
• Iphis and Anaxarete in Ovid's Metamorphoses: poem of the shut-out lover.Garakani A, Mendelsohn N. Iphis and Anaxarete in Ovid's Metamorphoses: poem of the shut-out lover. The American Journal Of Psychiatry 2013, 170: 721-2. PMID: 23820831, DOI: 10.1176/appi.ajp.2012.12101297.
• Proinflammatory and "resiliency" proteins in the CSF of patients with major depression.Martinez JM, Garakani A, Yehuda R, Gorman JM. Proinflammatory and "resiliency" proteins in the CSF of patients with major depression. Depression And Anxiety 2012, 29: 32-8. PMID: 21898706, DOI: 10.1002/da.20876.
• Clinician-rated versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance misuse.Goldberg JF, Garakani A, Ackerman SH. Clinician-rated versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance misuse. The Journal Of Clinical Psychiatry 2012, 73: 1525-30. PMID: 23290325, DOI: 10.4088/JCP.12m07926.
• Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists.Krystal JH, Mathew SJ, D'Souza DC, Garakani A, Gunduz-Bruce H, Charney DS. Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists. CNS Drugs 2010, 24: 669-93. PMID: 20658799, DOI: 10.2165/11533230-000000000-00000.
• Heart rate and blood pressure changes during autonomic nervous system challenge in panic disorder patients.Martinez JM, Garakani A, Kaufmann H, Aaronson CJ, Gorman JM. Heart rate and blood pressure changes during autonomic nervous system challenge in panic disorder patients. Psychosomatic Medicine 2010, 72: 442-9. PMID: 20368476, DOI: 10.1097/PSY.0b013e3181d972c2.
• The pharmacological treatment of bipolar disorder: the question of modern advances.Hirschowitz J, Kolevzon A, Garakani A. The pharmacological treatment of bipolar disorder: the question of modern advances. Harvard Review Of Psychiatry 2010, 18: 266-78. PMID: 20825264, DOI: 10.3109/10673229.2010.507042.
• Neurobiology of Anxiety DisordersAmiel, J,M,, Mathew, S,J,, Garakani, A,, Neumeister, A,, Charney, D,S. Neurobiology of Anxiety Disorders. In American Psychiatric Publishing Textbook of Psychopharmacology, 4th edition, eds. A.F. Schatzberg, C.B. Nemeroff. American Psychiatric Publishing, Inc., Washington, D.C., 2009. pp. 965–985.
• Anxiety Disorders: Neurochemical AspectsGarakani, A., Neumeister, A., Bonne, O., Charney, D.S. Anxiety Disorders: Neurochemical Aspects. In Kaplan and Sadock’s Comprehensive Textbook of Psychiatry, 9th edition, eds. B.J. Sadock, V.A. Sadock, P. Ruiz, Lippincott Williams & Wilkins, Philadelphia, PA, 2009, pp. 1871–1881.
• Effect of medication and psychotherapy on heart rate variability in panic disorder.Garakani A, Martinez JM, Aaronson CJ, Voustianiouk A, Kaufmann H, Gorman JM. Effect of medication and psychotherapy on heart rate variability in panic disorder. Depression And Anxiety 2009, 26: 251-8. PMID: 18839407, DOI: 10.1002/da.20533.
• The Neurobiology of Anxiety DisordersGarakani A, Murrough J, Charney DS, Bremner, JD. The neurobiology of anxiety disorders. In Neurobiology of Mental Illness. 3rd edition, eds. D.S. Charney, E.J. Nestler EJ. Oxford University Press, USA, New York, NY, 2008. pp. 605–628.
• A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder.Garakani A, Martinez JM, Marcus S, Weaver J, Rickels K, Fava M, Hirschowitz J. A randomized, double-blind, and placebo-controlled trial of quetiapine augmentation of fluoxetine in major depressive disorder. International Clinical Psychopharmacology 2008, 23: 269-75. PMID: 18703936, DOI: 10.1097/YIC.0b013e328301a74c.
• The effect of doxapram on brain imaging in patients with panic disorder.Garakani A, Buchsbaum MS, Newmark RE, Goodman C, Aaronson CJ, Martinez JM, Torosjan Y, Chu KW, Gorman JM. The effect of doxapram on brain imaging in patients with panic disorder. European Neuropsychopharmacology : The Journal Of The European College Of Neuropsychopharmacology 2007, 17: 672-86. PMID: 17560768, PMCID: PMC2695988, DOI: 10.1016/j.euroneuro.2007.04.002.
• Neurobiology of anxiety disorders and implications for treatment.Garakani A, Mathew SJ, Charney DS. Neurobiology of anxiety disorders and implications for treatment. The Mount Sinai Journal Of Medicine, New York 2006, 73: 941-9. PMID: 17195879.
• General disaster psychiatry.Garakani A, Hirschowitz J, Katz CL. General disaster psychiatry. The Psychiatric Clinics Of North America 2004, 27: 391-406. PMID: 15325484, DOI: 10.1016/j.psc.2004.03.002.
• Comorbidity of irritable bowel syndrome in psychiatric patients: a review.Garakani A, Win T, Virk S, Gupta S, Kaplan D, Masand PS. Comorbidity of irritable bowel syndrome in psychiatric patients: a review. American Journal Of Therapeutics 2003, 10: 61-7. PMID: 12522523.
• Electrolyte-balanced sports drink for polydipsia-hyponatremia in schizophrenia.Quitkin FM, Garakani A, Kelly KE. Electrolyte-balanced sports drink for polydipsia-hyponatremia in schizophrenia. The American Journal Of Psychiatry 2003, 160: 385-6. PMID: 12562594.
• Psychobiology of the acute stress response and its relationship to the psychobiology of post-traumatic stress disorder.Marshall RD, Garakani A. Psychobiology of the acute stress response and its relationship to the psychobiology of post-traumatic stress disorder. The Psychiatric Clinics Of North America 2002, 25: 385-95. PMID: 12136506.
• The prevalence of post-traumatic stress disorder related symptoms in Coronavirus outbreaks: A systematic-review and meta-analysis.Salehi M, Amanat M, Mohammadi M, Salmanian M, Rezaei N, Saghazadeh A, Garakani A. The prevalence of post-traumatic stress disorder related symptoms in Coronavirus outbreaks: A systematic-review and meta-analysis. Journal Of Affective Disorders 2021, 282: 527-538. PMID: 33433382, PMCID: PMC7831964, DOI: 10.1016/j.jad.2020.12.188.
• Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study.Amanat M, Rezaei N, Roozbeh M, Shojaei M, Tafakhori A, Zoghi A, Darazam IA, Salehi M, Karimialavijeh E, Lima BS, Garakani A, Vaccaro A, Ramezani M. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study. BMC Neurology 2021, 21: 116. PMID: 33726699, PMCID: PMC7960879, DOI: 10.1186/s12883-021-02152-5.
• Gaming to relieve tension or anxiety and associations with health functioning, substance use and physical violence in high school students.Garakani A, Zhai ZW, Hoff RA, Krishnan-Sarin S, Potenza MN. Gaming to relieve tension or anxiety and associations with health functioning, substance use and physical violence in high school students. Journal Of Psychiatric Research 2021, 140: 461-467. PMID: 34147933, DOI: 10.1016/j.jpsychires.2021.05.055.